This transaction unites two companies with strong histories of product innovation and a shared commitment to advancing therapeutic options for dialysis and intensive care patients globally. The completion of the acquisition marks the beginning for the integration of Baxter and Gambro.
We are committed to seamlessly integrating the businesses and continuing to provide you with the highest level of service, support and quality that you expect from us. In the meantime, please continue to work with your existing Baxter sales and customer support contacts for questions regarding Baxter products and your existing Gambro sales, service and customer support contacts for Gambro products.
Find out more
Gambro AB (including all direct and indirect subsidiaries) is now part of Baxter International Inc.
For the latest news go to the Baxter press room
Baxter press room
The leader in blood purification therapies in the hospital setting.
A therapy for myeloma kidney patients is now available. Thanks to the emergence of an innovative, new technology from Gambro.
SelectBag® Citrate is a unique citrate-containing, acetate-free concentrate developed by Gambro for regular hemodialysis and hemodiafiltration treatments.
Polyflux® is a versatile family of dialyzers allowing full therapy flexibility, matching the needs of both patients and the dialysis clinic.
© Gambro 2011